-
Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7
28 Apr 2025 10:00 GMT
… internationally recognized expert in mesothelioma, will be presenting the … cancer. For more information, visit www.portagebiotech.com … forward-looking statements or information, except as required … by law. For More Information:
Portage Biotech
Alexander Pickett …
-
Wife of Yorkshire dad appeals for information following asbestos death
28 Apr 2025 06:18 GMT
… miner is appealing for information relating to her husband… appealing for anyone with information about his work at … at which he died from mesothelioma. "Understandably, Carole has … exposure." Anyone with information can contact Oliver Collett at …
-
Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research (AACR) Annual Meeting
28 Apr 2025 12:00 GMT
… , small cell lung cancer, and mesothelioma, and CTX-471 has been … (BTC) is ongoing (clinical trial information: NCT05506943). About Compass Therapeutics Compass … in Boston, Massachusetts. For more information, visit the Compass Therapeutics website …
-
Understanding Your Legal Rights After an Asbestos-Related Diagnosis
27 Apr 2025 16:36 GMT
… compensation. This blog outlines essential information about asbestos exposure, associated … Legal Support
Why a Specialized Mesothelioma Lawyer Matters
Asbestos litigation … evidence requirements. A specialized mesothelioma lawyer in Georgia can provide …
-
KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
27 Apr 2025 16:10 GMT
… Selected Important Safety Information.
Selected Important Safety Information for KEYTRUDA
Severe … advanced or metastatic malignant pleural mesothelioma (MPM).
Classical Hodgkin Lymphoma … .gov).
Please see Prescribing Information for KEYTRUDA (pembrolizumab) at …
-
Harrowing photo shows devastating effects of asbestos exposure as family make huge plea for 'caring' Sheffield man
27 Apr 2025 03:16 GMT
… are appealing for any information about how he was … circumstances surrounding it. "Mesothelioma is a devastating illness and … to come forward with information to help Melanie honour … exposed." Anyone with information can contact Nick Woods at …
-
Destruction of asbestos evidence postponed; New companies join effort to preserve it
25 Apr 2025 20:58 GMT
… a defense verdict in a mesothelioma case in Los Angeles after … obligation to produce highly relevant information in current and future legal …
-
Devastated wife of former Glasshoughton Colliery worker appeals for help following his death from cancer
25 Apr 2025 15:54 GMT
… from Castleford, was diagnosed with mesothelioma, a cancer of the lining … workmates to come forward with information they may have on … , he was diagnosed with mesothelioma in November 2022.
He … from them.”
Anyone with information is asked to contact Oliver …
-
Verismo Therapeutics Announces Poster Presentation at ASCO 2025
25 Apr 2025 08:38 GMT
… advanced mesothelin-expressing ovarian cancer, mesothelioma, or cholangiocarcinoma.
Presenting Author: … disorders and malignancies. For more information, visit: www.verismotherapeutics.com … these statements as new information becomes available, except as …
-
Free Webinar for GBM Patients and Caregivers: the End Brain Cancer Initiative’s 2025 Know All Your Treatment Options
24 Apr 2025 14:19 GMT
… .telixpharma.com/ for further information.
About Novocure
Novocure is a … lung cancer, malignant pleural mesothelioma and pleural mesothelioma. Novocure has several additional … .novocure.com/ for further information.
About the End Brain Cancer …
About
© 1995-2025